Table 7 Drugs used by patients treated for protected (n = 95) and unprotected (n = 64) left main coronary artery (LMCA) disease at the end of long‐term follow‐up.

Drugs	Protected LMCA (n = 95)	Unprotected LMCA (n = 64)	p Value
Aspirin (%)	76	78	NS
Clopidogrel (%)	37	22	NS
Oral anticoagulants (%)	13	12	NS
β Blockers (%)	87	79	NS
ACE inhibitors (%)	73	62	NS
Statins (%)	84	78	NS
Calcium antagonists (%)	21	17	NS